Clostridium Difficile

Feature Article

Clostridium difficile Infection in the Intensive Care Setting

Clostridium difficile Infection in the Intensive Care Setting

It is important to understand the relative severity of CDI in patients in the ICU because it effects treatment decisions. However, primary prevention remains a vitally important strategy to limit morbidity and mortality related to CDI in this vulnerable patient population.

Latest News

C difficile Risk Higher With Stoma Reversal vs Colectomy

C difficile Risk Higher With Stoma Reversal vs Colectomy

Given the impact of postoperative Clostridium difficile infection, a heightened sense of suspicion should be given to symptomatic patients after stoma reversal.

Bezlotoxumab May Reduce Recurrent C difficile Infections in High-Risk Groups

Bezlotoxumab May Reduce Recurrent C difficile Infections in High-Risk Groups

Subgroup analyses of 2 MODIFY trial data confirmed prior C difficile infection (CDI), age ≥65 years, infection with 027/078/244 strain, compromised immunity, and severe CDI are risk factors for recurrent CDI.

Firvanq Availability Replaces Need for Compounded Oral Vancomycin Solution

Firvanq Availability Replaces Need for Compounded Oral Vancomycin Solution

FIRVANQ is commercially available in 25 and 50 mg/mL strengths in convenient 150 mL and 300 mL sizes.

Substantial Economic Burden Attributed to Recurrent Clostridium difficile

Substantial Economic Burden Attributed to Recurrent Clostridium difficile

Healthcare resource utilization and costs attributable to primary Clostridium difficile infection and recurrent C difficile infection are substantial.

C difficile Hospitalizations With Acute Kidney Injury Rising

C difficile Hospitalizations With Acute Kidney Injury Rising

Hospital admissions of patients with Clostridium difficile infection and accompanying acute kidney injury are increasing.

Extended-Pulsed Fidaxomicin Superior to Vancomycin for Sustained CDI Cure in Elderly

Extended-Pulsed Fidaxomicin Superior to Vancomycin for Sustained CDI Cure in Elderly

The EXTEND study addresses sustained cure as a primary measure of treatment success in a high-risk patient population, with recurrence monitored up to day 90.

Food Additive Linked to Growing Incidence of Clostridium difficile

Food Additive Linked to Growing Incidence of Clostridium difficile

Trehalose has been linked to the growing incidence and severity of healthcare-associated outbreaks caused by Clostridium difficile.

Probiotics Effective for Preventing C difficile-Associated Diarrhea

Probiotics Effective for Preventing C difficile-Associated Diarrhea

Short-term use of probiotics appears to be safe and effective when used along with antibiotics in patients who are not immunocompromised or severely debilitated.

Fecal Microbial Transplantation by Oral Capsule Not Inferior to Colonoscopy Delivery

Fecal Microbial Transplantation by Oral Capsule Not Inferior to Colonoscopy Delivery

A study investigated whether fecal microbiota transplantation delivered via oral capsules was as effective as microbiota delivered via colonoscopy for treating recurrent Clostridium difficile infection.

Prolonged Antibiotic Prophylaxis May Increase CDI Risk After Cardiac Surgery

Prolonged Antibiotic Prophylaxis May Increase CDI Risk After Cardiac Surgery

Readmissions for CDI occurred close to hospital discharge, consistent with the CDC's surveillance study findings.

Sign Up for Free e-newsletters